625 results on '"Sahakian BJ"'
Search Results
2. Do people recover from the impact of COVID-19 social isolation? Social connectivity and negative affective bias
- Author
-
Bland, AR, Roiser, JP, Mehta, MA, Robbins, TW, Elliott, R, Sahakian, BJ, Bland, AR, Roiser, JP, Mehta, MA, Robbins, TW, Elliott, R, and Sahakian, BJ
- Published
- 2024
3. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
- Author
-
Goodwin, GM, Haddad, PM, Ferrier, IN, Aronson, JK, Barnes, TRH, Cipriani, A, Coghill, Fazel, S, Geddes, Grunze, H, Holmes, EA, Howes, O, Hudson, S, Hunt, N, Jones, I, Macmillan, IC, McAllister-Williams, H, Miklowitz, Morriss, R, Munafò, M, Paton, C, Sahakian, BJ, Saunders, KEA, Sinclair, JMA, Taylor, D, Vieta, E, and Young, AH
- Subjects
Biomedical and Clinical Sciences ,Clinical Research ,Clinical Trials and Supportive Activities ,Prevention ,Mental health ,Antidepressive Agents ,Bipolar Disorder ,Combined Modality Therapy ,Consensus ,Diagnosis ,Differential ,Evidence-Based Medicine ,Humans ,Medication Adherence ,Patient Education as Topic ,Practice Guidelines as Topic ,Psychopharmacology ,Secondary Prevention ,Bipolar disorder ,treatment ,evidence-based guidelines ,antipsychotics ,antidepressants ,mood stabilizers ,lithium ,psychoeducation ,cognitive behaviour therapy ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Biomedical and clinical sciences ,Health sciences - Abstract
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.
- Published
- 2016
4. Motor disorders
- Author
-
Boyle, GJ, Stern, Y, Stein, DJ, Sahakian, BJ, Golden, CJ, Mei-Chun Lee, T, Shen-Hsing Chen, A, Cavanna, A, Nani, A, Cavanna, AE, Boyle, GJ, Stern, Y, Stein, DJ, Sahakian, BJ, Golden, CJ, Mei-Chun Lee, T, Shen-Hsing Chen, A, Cavanna, A, Nani, A, and Cavanna, AE
- Published
- 2023
5. Gambling disorder in the UK: key research priorities and the urgent need for independent research funding
- Author
-
Bowden-Jones, H, Hook, RW, Grant, JE, Ioannidis, K, Corazza, O, Fineberg, NA, Singer, BF, Roberts, A, Bethlehem, R, Dymond, S, Romero-Garcia, R, Robbins, TW, Cortese, S, Thomas, SA, Sahakian, BJ, Dowling, NA, Chamberlain, SR, Bowden-Jones, H, Hook, RW, Grant, JE, Ioannidis, K, Corazza, O, Fineberg, NA, Singer, BF, Roberts, A, Bethlehem, R, Dymond, S, Romero-Garcia, R, Robbins, TW, Cortese, S, Thomas, SA, Sahakian, BJ, Dowling, NA, and Chamberlain, SR
- Abstract
Gambling in the modern era is pervasive owing to the variety of gambling opportunities available, including those that use technology (eg, online applications on smartphones). Although many people gamble recreationally without undue negative effects, a sizeable subset of individuals develop disordered gambling, which is associated with marked functional impairment including other mental health problems, relationship problems, bankruptcy, suicidality, and criminality. The National UK Research Network for Behavioural Addictions (NUK-BA) was established to promote understanding of, research into, and treatments for behavioural addictions including gambling disorder, which is the only formally recognised behavioural addiction. In this Health Policy paper, we outline the status of research and treatment for disordered gambling in the UK (including funding issues) and key research that should be conducted to establish the magnitude of the problem, vulnerability and resilience factors, the underlying neurobiology, long-term consequences, and treatment opportunities. In particular, we emphasise the need to: (1) conduct independent longitudinal research into the prevalence of disordered gambling (including gambling disorder and at-risk gambling), and gambling harms, including in vulnerable and minoritised groups; (2) select and refine the most suitable pragmatic measurement tools; (3) identify predictors (eg, vulnerability and resilience markers) of disordered gambling in people who gamble recreationally, including in vulnerable and minoritised groups; (4) conduct randomised controlled trials on psychological interventions and pharmacotherapy for gambling disorder; (5) improve understanding of the neurobiological basis of gambling disorder, including impulsivity and compulsivity, genetics, and biomarkers; and (6) develop clinical guidelines based on the best contemporary research evidence to guide effective clinical interventions. We also highlight the need to consider what
- Published
- 2022
6. Heritability of specific cognitive functions and associations with schizophrenia spectrum disorders using CANTAB: a nation-wide twin study
- Author
-
Lemvigh, CK, Brouwer, RM, Pantelis, C, Jensen, MH, Hilker, RW, Legind, CS, Anhoj, SJ, Robbins, TW, Sahakian, BJ, Glenthoj, BY, Fagerlund, B, Lemvigh, CK, Brouwer, RM, Pantelis, C, Jensen, MH, Hilker, RW, Legind, CS, Anhoj, SJ, Robbins, TW, Sahakian, BJ, Glenthoj, BY, and Fagerlund, B
- Abstract
BACKGROUND: Many cognitive functions are under strong genetic control and twin studies have demonstrated genetic overlap between some aspects of cognition and schizophrenia. How the genetic relationship between specific cognitive functions and schizophrenia is influenced by IQ is currently unknown. METHODS: We applied selected tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) to examine the heritability of specific cognitive functions and associations with schizophrenia liability. Verbal and performance IQ were estimated using The Wechsler Adult Intelligence Scale-III and the Danish Adult Reading Test. In total, 214 twins including monozygotic (MZ = 32) and dizygotic (DZ = 22) pairs concordant or discordant for a schizophrenia spectrum disorder, and healthy control pairs (MZ = 29, DZ = 20) were recruited through the Danish national registers. Additionally, eight twins from affected pairs participated without their sibling. RESULTS: Significant heritability was observed for planning/spatial span (h2 = 25%), self-ordered spatial working memory (h2 = 64%), sustained attention (h2 = 56%), and movement time (h2 = 47%), whereas only unique environmental factors contributed to set-shifting, reflection impulsivity, and thinking time. Schizophrenia liability was associated with planning/spatial span (rph = -0.34), self-ordered spatial working memory (rph = -0.24), sustained attention (rph = -0.23), and set-shifting (rph = -0.21). The association with planning/spatial span was not driven by either performance or verbal IQ. The remaining associations were shared with performance, but not verbal IQ. CONCLUSIONS: This study provides further evidence that some cognitive functions are heritable and associated with schizophrenia, suggesting a partially shared genetic etiology. These functions may constitute endophenotypes for the disorder and provide a basis to explore genes common to cognition and schizophrenia.
- Published
- 2022
7. COVID-19 induced social isolation; implications for understanding social cognition in mental health
- Author
-
Bland, AR, Roiser, JP, Mehta, MA, Sahakian, BJ, Robbins, TW, Elliott, R, Bland, AR, Roiser, JP, Mehta, MA, Sahakian, BJ, Robbins, TW, and Elliott, R
- Published
- 2022
8. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers
- Author
-
Savulich, G, Piercy, T, Brühl, AB, Fox, C, Suckling, J, Rowe, JB, OʼBrien, JT, and Sahakian, BJ
- Published
- 2017
- Full Text
- View/download PDF
9. #3071 Acute escitalopram administration increases premature responding as a function of reward magnitude in healthy male volunteers
- Author
-
Skandali, N, primary, Sahakian, BJ, additional, Robbins, TWR, additional, and Voon, V, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Dopaminergic modulation of reinforcement learning in stimulant drug addiction
- Author
-
Lim, TV, Cardinal, RN, Meng, C, Murray, GK, Craig, KJ, Abbott, S, Shabbir, SS, Suckling, J, Sahakian, BJ, Bullmore, ET, Robbins, TW, and Ersche, KD
- Subjects
nervous system ,52 Psychology ,5202 Biological Psychology ,3209 Neurosciences ,32 Biomedical and Clinical Sciences - Abstract
Background: Chronic stimulant use has been associated with disruptions in fronto-striatal systems implicated in as- sociative learning [1]. Experimental studies have also shown that individuals with stimulant drug addiction experience difficulties in selecting the appropriate action following feedback [2]. However, the precise impairments in feedback learning in stimulant-addicted individuals are still unclear. A possible explanation might lie in an abnormal prediction error mechanism, as stimulant drugs directly target striatal dopaminergic neurons [3].
- Published
- 2020
- Full Text
- View/download PDF
11. COVID-19 induced social isolation; implications for understanding social cognition in mental health
- Author
-
Bland, AR, Roiser, JP, Mehta, MA, Sahakian, BJ, Robbins, TW, Elliott, R, Bland, AR, Roiser, JP, Mehta, MA, Sahakian, BJ, Robbins, TW, and Elliott, R
- Published
- 2020
12. Agency and intentionality-dependent experiences of moral emotions
- Author
-
Bland, AR, Schei, T, Roiser, JP, Mehta, MA, Zahn, R, Seara-Cardoso, A, Viding, E, Sahakian, BJ, Robbins, TW, Elliott, R, Bland, AR, Schei, T, Roiser, JP, Mehta, MA, Zahn, R, Seara-Cardoso, A, Viding, E, Sahakian, BJ, Robbins, TW, and Elliott, R
- Abstract
Moral emotions are thought to influence moral behaviour by providing a driving force to do good and to avoid doing bad. In this study we examined moral emotions; specifically, guilt, shame, annoyance and feeling “bad” from two different perspectives in a moral scenario; the agent and the victim whilst manipulating the intentionality of the harm; intentional and unintentional. Two hundred participants completed a moral emotions task, which utilised cartoons to depict everyday moral scenarios. As expected, we found that self-blaming emotions such as shame and guilt were much more frequent when taking on the perspective of the agent whilst annoyance was more frequent from the victim perspective. Feeling bad, however, was not agency-specific. Notably, when the harm was intentional, we observed significantly greater shame ratings from the perspective of the agent compared to when the harm was unintentional. In addition, we also found clear gender differences and further observed correlations between moral emotions and personality variables such as psychoticism and neuroticism.
- Published
- 2020
13. Heritability of Memory Functions and Related Brain Volumes: A Schizophrenia Spectrum Study of 214 Twins
- Author
-
Lemvigh, CK, Brouwer, RM, Sahakian, BJ, Robbins, TW, Johansen, LB, Legind, CS, Anhøj, SJ, Hilker, R, Hulshoff Pol, HE, Ebdrup, BH, Pantelis, C, Glenthøj, BY, Fagerlund, B, Lemvigh, CK, Brouwer, RM, Sahakian, BJ, Robbins, TW, Johansen, LB, Legind, CS, Anhøj, SJ, Hilker, R, Hulshoff Pol, HE, Ebdrup, BH, Pantelis, C, Glenthøj, BY, and Fagerlund, B
- Abstract
Background Memory performance is heritable and shares partial genetic etiology with schizophrenia. How the genetic overlap between memory and schizophrenia is related to intelligence (IQ) and brain volumes has not been formally tested using twin modeling. Methods A total of 214 twins were recruited nationwide by utilization of the Danish registers, including monozygotic and dizygotic twin pairs concordant or discordant for a schizophrenia spectrum disorder and healthy control pairs. Memory/IQ assessments and MRI scans were performed and structural equation modeling was applied to examine the genetic and environmental effects and to quantify associations with schizophrenia liability. Results Significant heritability estimates were found for verbal, visual and working memory. Verbal and visual memory were associated with schizophrenia, and for visual memory the association was due to overlapping genetics. IQ was highly heritable, but only performance IQ was associated with schizophrenia. Genetic factors also contributed to total brain, right superior frontal, left rostral middle frontal and hippocampal volumes. Smaller total brain and hippocampal volumes were associated with schizophrenia, and for the left hippocampus this association was due to overlapping genetic factors. All 3 memory measures were associated with IQ, but only visual memory was associated with total brain and hippocampal volumes. Discussion Specific memory measures and brain volumes were moderately heritable and showed overlap with schizophrenia liability, suggesting partially shared etiological influences. Our findings further suggest that factors impacting IQ also influence memory, whereas memory impairments and brain volume abnormalities appear to represent separate pathological processes in the pathway to schizophrenia.
- Published
- 2020
14. Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and poly-substance dependent individuals
- Author
-
Nestor, LJ, Paterson, LM, Murphy, A, McGonigle, J, Orban, C, Reed, L, Taylor, E, Flechais, R, Smith, D, Bullmore, ET, Ersche, KD, Suckling, J, Elliott, R, Deakin, B, Rabiner, I, Lingford Hughes, A, Sahakian, BJ, Robbins, TW, Nutt, DJ, and Medical Research Council (MRC)
- Subjects
Neurology & Neurosurgery ,1701 Psychology ,1702 Cognitive Sciences ,mental disorders ,functional MRI ,impulsivity ,addiction ,naltrexone ,1109 Neurosciences ,behavioral disciplines and activities ,ICCAM Consortium - Abstract
Identifying key neural substrates in addiction disorders for targeted drug development remains a major challenge for clinical neuroscience. One emerging target is the opioid system, where substance‐dependent populations demonstrate prefrontal opioid dysregulation that predicts impulsivity and relapse. This may suggest that disturbances to the prefrontal opioid system could confer a risk for relapse in addiction due to weakened “top‐down” control over impulsive behaviour. Naltrexone is currently licensed for alcohol dependence and is also used clinically for impulse control disorders. Using a go/no‐go (GNG) task we examined the effects of acute naltrexone on the neural correlates of successful motor impulse control in abstinent alcoholics (AUD), abstinent poly substance‐dependent (poly‐SUD) individuals, and controls during a randomized double blind placebo controlled fMRI study. In the absence of any differences on GNG task performance, the AUD group showed a significantly greater BOLD response compared to the control group in lateral and medial prefrontal regions during both placebo and naltrexone treatments; effects that were positively correlated with alcohol abstinence. There was also a dissociation in the positive modulating effects of naltrexone in the orbitofrontal cortex (OFC) and anterior insula cortex (AIC) of the AUD and poly‐SUD groups respectively. Self‐reported trait impulsivity in the poly‐SUD group also predicted the effect of naltrexone in the AIC. These results suggest that acute naltrexone differentially amplifies neural responses within two distinct regions of a salience network during successful motor impulse control in abstinent AUD and poly‐SUD groups, which are predicted by trait impulsivity in the poly‐SUD group.
- Published
- 2018
15. Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals
- Author
-
Morris, LS, Baek, K, Tait, R, Elliott, R, Ersche, KD, Flechais, R, McGonigle, J, Murphy, A, Nestor, LJ, Orban, C, Passetti, F, Paterson, LM, Rabiner, I, Reed, L, Smith, D, Suckling, J, Taylor, EM, Bullmore, ET, Lingford-Hughes, AR, Deakin, B, Nutt, DJ, Sahakian, BJ, Robbins, TW, Voon, V, ICCAM Consortium, Ersche, Karen [0000-0002-3203-1878], Suckling, John [0000-0002-5098-1527], Bullmore, Edward [0000-0002-8955-8283], Sahakian, Barbara [0000-0001-7352-1745], Robbins, Trevor [0000-0003-0642-5977], Voon, Valerie [0000-0001-6790-1776], Apollo - University of Cambridge Repository, and Medical Research Council (MRC)
- Subjects
17 Psychology And Cognitive Sciences ,alcohol ,Substance Abuse ,cocaine ,substance use ,11 Medical And Health Sciences ,addiction ,naltrexone ,ICCAM Consortium ,opiate - Abstract
Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in alcohol and opiate addiction, but its efficacy and the mechanisms underpinning its clinical usefulness are not well characterized. In the current study, we examined the effects of 50-mg naltrexone compared with placebo on neural network changes associated with substance dependence in 21 alcohol and 36 poly-drug-dependent individuals compared with 36 healthy volunteers. Graph theoretic and network-based statistical analysis of resting-state functional magnetic resonance imaging (MRI) data revealed that alcohol-dependent subjects had reduced functional connectivity of a dispersed network compared with both poly-drug-dependent and healthy subjects. Higher local efficiency was observed in both patient groups, indicating clustered and segregated network topology and information processing. Naltrexone normalized heightened local efficiency of the neural network in alcohol-dependent individuals, to the same levels as healthy volunteers. Naltrexone failed to have an effect on the local efficiency in abstinent poly-substance-dependent individuals. Across groups, local efficiency was associated with substance, but no alcohol exposure implicating local efficiency as a potential premorbid risk factor in alcohol use disorders that can be ameliorated by naltrexone. These findings suggest one possible mechanism for the clinical effects of naltrexone, namely, the amelioration of disrupted network topology.
- Published
- 2018
16. Atomoxetine restores the response inhibition network in Parkinson's disease
- Author
-
Rae, CL, Rodríguez, PV, Ye, Z, Hughes, LE, Jones, PS, Ham, T, Rittman, T, Coyle-Gilchrist, I, Regenthal, R, Sahakian, BJ, Barker, RA, Robbins, TW, Rowe, JB, Hughes, Laura [0000-0002-1065-7175], Jones, Simon [0000-0001-9695-0702], Rittman, Timothy [0000-0003-1063-6937], Sahakian, Barbara [0000-0001-7352-1745], Barker, Roger [0000-0001-8843-7730], Robbins, Trevor [0000-0003-0642-5977], Rowe, James [0000-0001-7216-8679], and Apollo - University of Cambridge Repository
- Subjects
effective connectivity ,Parkinson’s disease ,response inhibition ,stop-signal task ,atomoxetine - Abstract
Parkinson's disease impairs the inhibition of responses, and whilst impulsivity is mild for some patients, severe impulse control disorders affect ∼10% of cases. Based on preclinical models we proposed that noradrenergic denervation contributes to the impairment of response inhibition, via changes in the prefrontal cortex and its subcortical connections. Previous work in Parkinson's disease found that the selective noradrenaline reuptake inhibitor atomoxetine could improve response inhibition, gambling decisions and reflection impulsivity. Here we tested the hypotheses that atomoxetine can restore functional brain networks for response inhibition in Parkinson's disease, and that both structural and functional connectivity determine the behavioural effect. In a randomized, double-blind placebo-controlled crossover study, 19 patients with mild-to-moderate idiopathic Parkinson's disease underwent functional magnetic resonance imaging during a stop-signal task, while on their usual dopaminergic therapy. Patients received 40 mg atomoxetine or placebo, orally. This regimen anticipates that noradrenergic therapies for behavioural symptoms would be adjunctive to, not a replacement for, dopaminergic therapy. Twenty matched control participants provided normative data. Arterial spin labelling identified no significant changes in regional perfusion. We assessed functional interactions between key frontal and subcortical brain areas for response inhibition, by comparing 20 dynamic causal models of the response inhibition network, inverted to the functional magnetic resonance imaging data and compared using random effects model selection. We found that the normal interaction between pre-supplementary motor cortex and the inferior frontal gyrus was absent in Parkinson's disease patients on placebo (despite dopaminergic therapy), but this connection was restored by atomoxetine. The behavioural change in response inhibition (improvement indicated by reduced stop-signal reaction time) following atomoxetine correlated with structural connectivity as measured by the fractional anisotropy in the white matter underlying the inferior frontal gyrus. Using multiple regression models, we examined the factors that influenced the individual differences in the response to atomoxetine: the reduction in stop-signal reaction time correlated with structural connectivity and baseline performance, while disease severity and drug plasma level predicted the change in fronto-striatal effective connectivity following atomoxetine. These results suggest that (i) atomoxetine increases sensitivity of the inferior frontal gyrus to afferent inputs from the pre-supplementary motor cortex; (ii) atomoxetine can enhance downstream modulation of frontal-subcortical connections for response inhibition; and (iii) the behavioural consequences of treatment are dependent on fronto-striatal structural connections. The individual differences in behavioural responses to atomoxetine highlight the need for patient stratification in future clinical trials of noradrenergic therapies for Parkinson's disease.
- Published
- 2017
- Full Text
- View/download PDF
17. Adolescent Major Depressive Disorder: Neuroimaging Evidence of Sex Difference during an Affective Go/No-Go Task
- Author
-
Chuang, J-Y, Hagan, CC, Murray, GK, Graham, JME, Ooi, C, Tait, R, Holt, RJ, Elliott, R, van Nieuwenhuizen, AO, Bullmore, ET, Lennox, BR, Sahakian, BJ, Goodyer, IM, Suckling, J, Murray, Graham [0000-0001-8296-1742], Bullmore, Edward [0000-0002-8955-8283], Sahakian, Barbara [0000-0001-7352-1745], Goodyer, Ian [0000-0001-9183-0373], Suckling, John [0000-0002-5098-1527], and Apollo - University of Cambridge Repository
- Subjects
Psychiatry ,Adolescent major depressive disorder ,Affective go/no-go task ,cerebellum ,Cerebellum ,sex difference ,mental disorders ,affective go/no-go task ,supramarginal gyrus ,adolescent major depressive disorder ,Supramarginal gyrus ,behavioral disciplines and activities ,Original Research - Abstract
Compared to female major depressive disorder (MDD), male MDD often receives less attention. However, research is warranted since there are significant sex differences in the clinical presentation of MDD and a higher rate of suicide in depressed men. To the best of our knowledge, this is the first functional magnetic resonance imaging (fMRI) study with a large sample addressing putative sex differences in MDD during adolescence, a period when one of the most robust findings in psychiatric epidemiology emerges; that females are twice as likely to suffer from MDD than males. Twenty-four depressed and 10 healthy male adolescents, together with 82 depressed and 24 healthy female adolescents, aged 11-18 years, undertook an affective go/no-go task during fMRI acquisition. In response to sad relative to neutral distractors, significant sex differences (in the supramarginal gyrus) and group-by-sex interactions (in the supramarginal gyrus and the posterior cingulate cortex) were found. Furthermore, in contrast to the healthy male adolescents, depressed male adolescents showed decreased activation in the cerebellum with a significant group-by-age interaction in connectivity. Future research may consider altered developmental trajectories and the possible implications of sex-specific treatment and prevention strategies for MDD.
- Published
- 2017
18. Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery
- Author
-
Savulich, G, Riccelli, R, Passamonti, L, Correia, M, Deakin, JFW, Elliott, R, Flechais, RSA, Lingford-Hughes, AR, McGonigle, J, Murphy, A, Nutt, DJ, Orban, C, Paterson, LM, Reed, LJ, Smith, DG, Suckling, J, Tait, R, Taylor, EM, Sahakian, BJ, Robbins, TW, Ersche, KD, ICCAM Platform, Passamonti, Luca [0000-0002-7937-0615], Morgado Correia, Marta [0000-0002-3231-7040], Suckling, John [0000-0002-5098-1527], Sahakian, Barbara [0000-0001-7352-1745], Robbins, Trevor [0000-0003-0642-5977], Ersche, Karen [0000-0002-3203-1878], and Apollo - University of Cambridge Repository
- Subjects
Adult ,Male ,Cross-Over Studies ,Substance-Related Disorders ,Functional Neuroimaging ,Narcotic Antagonists ,Brain ,Prefrontal Cortex ,Middle Aged ,Amygdala ,Opioid-Related Disorders ,Gyrus Cinguli ,Hippocampus ,Magnetic Resonance Imaging ,Naltrexone ,Alcoholism ,Cocaine-Related Disorders ,Young Adult ,Adult Survivors of Child Adverse Events ,Double-Blind Method ,Case-Control Studies ,Neural Pathways ,Humans ,Female ,Cues - Abstract
Naltrexone is an opioid receptor antagonist used in the management of alcohol dependence. Although the endogenous opioid system has been implicated in emotion regulation, the effects of mu-opioid receptor blockade on brain systems underlying negative emotional processing are not clear in addiction. Individuals meeting criteria for alcohol dependence alone ($\textit{n}$=18, alcohol) and in combination with cocaine and/or opioid dependence ($\textit{n}$=21, alcohol/drugs) and healthy individuals without a history of alcohol or drug dependence ($\textit{n}$=21) were recruited. Participants were alcohol and drug abstinent before entered into this double-blind, placebo-controlled, randomized, crossover study. Functional magnetic resonance imaging was used to investigate brain response while viewing aversive and neutral images relative to baseline on 50 mg of naltrexone and placebo. We found that naltrexone modulated task-related activation in the medial prefrontal cortex and functional connectivity between the anterior cingulate cortex and the hippocampus as a function of childhood adversity (for aversive versus neutral images) in all groups. Furthermore, there was a group-by-treatment-by-condition interaction in the right amygdala, which was mainly driven by a normalization of response for aversive relative to neutral images under naltrexone in the alcohol/drugs group. We conclude that early childhood adversity is one environmental factor that influences pharmacological response to naltrexone. Pharmacotherapy with naltrexone may also have some ameliorative effects on negative emotional processing in combined alcohol and drug dependence, possibly due to alterations in endogenous opioid transmission or the kappa-opioid receptor antagonist actions of naltrexone.
- Published
- 2017
19. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals
- Author
-
Passamonti, L, Luijten, M, Ziauddeen, H, Coyle-Gilchrist, I, Rittman, T, Brain, S, Regenthal, R, Franken, Ingmar, Sahakian, BJ, Robbins, T, Ersche, K, Passamonti, L, Luijten, M, Ziauddeen, H, Coyle-Gilchrist, I, Rittman, T, Brain, S, Regenthal, R, Franken, Ingmar, Sahakian, BJ, Robbins, T, and Ersche, K
- Published
- 2017
20. Mood state moderates the role of serotonin in cognitive biases
- Author
-
Robinson, OJ, Cools, R., Crockett, MJ, and Sahakian, BJ
- Subjects
Set (Psychology) -- Research ,Serotonin agonists -- Health aspects ,Depression, Mental -- Drug therapy ,Pharmaceuticals and cosmetics industries ,Psychology and mental health - Published
- 2010
21. Divergent subcortical activity for distinct executive functions: stopping and shifting in obsessive compulsive disorder
- Author
-
Morein-Zamir, S, Voon, V, Dodds, CM, Sule, A, van Niekerk, J, Sahakian, BJ, Robbins, TW, Voon, Valerie [0000-0001-6790-1776], Sahakian, Barbara [0000-0001-7352-1745], Robbins, Trevor [0000-0003-0642-5977], and Apollo - University of Cambridge Repository
- Subjects
Adult ,Obsessive-Compulsive Disorder ,shifting ,Cognitive flexibility ,behavioral disciplines and activities ,stopping ,Executive Function ,Cognition ,Thalamus ,Parietal Lobe ,Task Performance and Analysis ,mental disorders ,Humans ,response inhibition ,OCD ,Functional Neuroimaging ,functional magnetic resonance imaging (fMRI) ,Brain ,Middle Aged ,Magnetic Resonance Imaging ,humanities ,Frontal Lobe ,Neostriatum ,Case-Control Studies ,Caudate Nucleus ,Arousal - Abstract
Background:\ud There is evidence of executive function impairment in obsessive compulsive disorder (OCD) that potentially contributes to symptom development and maintenance. Nevertheless, the precise nature of these executive impairments and their neural basis remains to be defined.\ud \ud \ud Method:\ud We compared stopping and shifting, two key executive functions previously implicated in OCD, in the same task using functional magnetic resonance imaging, in patients with virtually no co-morbidities and age-, verbal IQ- and gender-matched healthy volunteers. The combined task allowed direct comparison of neural activity in stopping and shifting independent of patient sample characteristics and state variables such as arousal, learning, or current symptom expression.\ud \ud \ud Results:\ud Both OCD patients and controls exhibited right inferior frontal cortex activation during stopping, and left inferior parietal cortex activation during shifting. However, widespread under-activation across frontal-parietal areas was found in OCD patients compared to controls for shifting but not stopping. Conservative, whole-brain analyses also indicated marked divergent abnormal activation in OCD in the caudate and thalamus for these two cognitive functions, with stopping-related over-activation contrasting with shift-related under-activation.\ud \ud \ud Conclusions:\ud OCD is associated with selective components of executive function, which engage similar common elements of cortico-striatal regions in different abnormal ways. The results implicate altered neural activation of subcortical origin in executive function abnormalities in OCD that are dependent on the precise cognitive and contextual requirements, informing current theories of symptom expression.
- Published
- 2016
22. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers
- Author
-
Savulich, G, primary, Piercy, T, additional, Brühl, AB, additional, Fox, C, additional, Suckling, J, additional, Rowe, JB, additional, O'Brien, JT, additional, and Sahakian, BJ, additional
- Published
- 2016
- Full Text
- View/download PDF
23. Restructuring of functional connectivity in motor network after traumatic brain injury (TBI).
- Author
-
Kasahara, M, primary, Menon, DK, additional, Salmond, CH, additional, Outtrim, JG, additional, Tavares, JV Taylor, additional, Carpenter, TA, additional, Sahakian, BJ, additional, and Stamatakis, EA, additional
- Published
- 2009
- Full Text
- View/download PDF
24. Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
- Author
-
Winder-Rhodes, SE, primary, Chamberlain, SR, additional, Idris, MI, additional, Robbins, TW, additional, Sahakian, BJ, additional, and Müller, U, additional
- Published
- 2009
- Full Text
- View/download PDF
25. Paradoxical enhancement of choice reaction time performance in patients with major depression
- Author
-
Chase, HW, primary, Michael, A., additional, Bullmore, ET, additional, Sahakian, BJ, additional, and Robbins, TW, additional
- Published
- 2009
- Full Text
- View/download PDF
26. Mood state moderates the role of serotonin in cognitive biases
- Author
-
Robinson, OJ, primary, Cools, R., additional, Crockett, MJ, additional, and Sahakian, BJ, additional
- Published
- 2009
- Full Text
- View/download PDF
27. Disrupted `reflection' impulsivity in cannabis users but not current or former ecstasy users
- Author
-
Clark, L., primary, Roiser, JP, additional, Robbins, TW, additional, and Sahakian, BJ, additional
- Published
- 2009
- Full Text
- View/download PDF
28. Dopaminergic modulation of manipulation processes in human working memory – critical involvement of D2 receptors and the ventral striatum
- Author
-
Müller, U, primary, Dodds, C, additional, Dove, A, additional, van Loun, A, additional, Owen, A, additional, Regenthal, R, additional, Sahakian, BJ, additional, Bullmore, ET, additional, Clark, L, additional, and Robbins, TW, additional
- Published
- 2007
- Full Text
- View/download PDF
29. Using cognitive profiling to aid diagnosis and monitor or predict recovery in idiopathic normal pressure hydrocephalus
- Author
-
Loveday, C, primary, Iddon, JL, additional, Sahakian, BJ, additional, Best, M, additional, and Pickard, JD, additional
- Published
- 2006
- Full Text
- View/download PDF
30. Effects of methylphenidate on cognition and apathy in normal pressure hydrocephalus: A case study and review
- Author
-
Keenan, S, primary, Mavaddat, N, additional, Iddon, J, additional, Pickard, JD, additional, and Sahakian, BJ, additional
- Published
- 2005
- Full Text
- View/download PDF
31. Differential cognitive deterioration in dementia: a two year longitudinal study.
- Author
-
Chamberlain SR, Blackwell AD, Nathan PJ, Hammond G, Robbins TW, Hodges JR, Michael A, Semple JM, Bullmore ET, and Sahakian BJ
- Published
- 2011
- Full Text
- View/download PDF
32. Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers.
- Author
-
Winder-Rhodes, SE, Chamberlain, SR, Idris, MI, Robbins, TW, Sahakian, BJ, and Müller, U
- Abstract
Previous research has demonstrated cognitive-enhancing effects of modafinil in humans and generated evidence for its therapeutic potential in psychiatric disorders. The neurochemical basis of these effects remains unresolved although a role for α1-adrenoceptors has been hypothesised. In this within-subject, double-blind, placebo-controlled study, 12 healthy male adults received modafinil (300 mg), the α1-adrenoceptor antagonist prazosin (3 mg), both together and placebo on separate occasions at least 5 days apart. Cognitive effects were assessed using a well-validated testing battery focusing on executive and working memory functions. Blood pressure, heart rate and salivary α-amylase (sAA) were measured at hourly intervals. Cognitive effects of modafinil and prazosin were identified at the difficult levels of the One-Touch Stockings of Cambridge (OTSOC) planning task. Prazosin antagonized the error-reducing effect of modafinil when the agents were given together. In contrast, the combined agents acted synergistically to increase time taken to complete OTSOC problems compared with placebo. The tachycardic and sAA-elevating effects of prazosin were also potentiated by concurrent modafinil administration. The current data suggest that the cognitive effects of modafinil on performance accuracy and latency are dissociable in terms of their neurochemical mechanisms. Our findings support the hypothesised involvement of α1-adrenoceptors in some of the cognitive-enhancing effects of modafinil and warrant further investigation. [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
33. Altered functional connectivity in the motor network after traumatic brain injury.
- Author
-
Kasahara M, Menon DK, Salmond CH, Outtrim JG, Taylor Tavares JV, Carpenter TA, Pickard JD, Sahakian BJ, Stamatakis EA, Kasahara, M, Menon, D K, Salmond, C H, Outtrim, J G, Taylor Tavares, J V, Carpenter, T A, Pickard, J D, Sahakian, B J, and Stamatakis, E A
- Published
- 2010
- Full Text
- View/download PDF
34. Memory and executive impairment in schizophrenia: comparison with frontal and temporal brain damage.
- Author
-
Ornstein TJ, Sahakian BJ, and McKenna PJ
- Abstract
BACKGROUND: Although poor neuropsychological test performance is well documented in schizophrenia, how closely it resembles that seen in patients with brain damage in terms of cognitive failures in daily life and stability over time has been little studied.MethodThirty patients with chronic schizophrenia, 24 patients with frontal or temporal brain damage and 30 healthy controls were given a battery of memory and executive tests. Carers of the two patient groups also completed questionnaires rating memory and executive failures in daily life. Testing was repeated 6 weeks later. RESULTS: The schizophrenia and the brain-damaged patients were significantly impaired on most, but not all tests. The degree of carer-rated memory or executive failure was similar in the two groups, but the schizophrenia patients were rated as having significantly more executive failures than memory failures, whereas the brain-damaged patients showed the reverse pattern. Both groups of patients showed similar consistency of performance across sessions. CONCLUSIONS: Neuropsychological impairment in schizophrenia resembles that seen in patients with brain damage, not only in terms of overall severity, but also in terms of stability and the degree to which poor test performance translates into cognitive failures in daily life. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
35. Recurrence in major depressive disorder: a neurocognitive perspective.
- Author
-
Robinson OJ and Sahakian BJ
- Abstract
ABSTRACTDepressive disorders are amongst the leading causes of disability and mortality worldwide and, as such, it is predicted that by 2010 only cardio-ischaemic disorders will provide a greater burden. In addition to the sizable emotional, individual and social burden, depressive disorders cost an estimated US$83.1 billion per year in the United States alone. In spite of effective treatments, a large proportion of sufferers go on to experience recurrences. With successive recurrences, the likelihood of subsequent episodes increases. Despite this, research to date has tended to focus on first episodes or else has not distinguished between episodes. This editorial review highlights a number of differences between first and recurrent episodes which, in turn, recommend more longitudinal, recurrence-oriented, treatments. We also examine the findings from acute tryptophan depletion studies which, it is speculated, help to understand the differences between successive episodes. The overall aim, however, is to highlight the importance of recurrence in depression and to stimulate debate. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
36. The neuropsychiatry of impulsivity.
- Author
-
Chamberlain SR, Sahakian BJ, Chamberlain, Samuel R, and Sahakian, Barbara J
- Published
- 2007
- Full Text
- View/download PDF
37. Neuropharmacological modulation of cognition.
- Author
-
Chamberlain SR, Müller U, Robbins TW, Sahakian BJ, Chamberlain, Samuel R, Müller, Ulrich, Robbins, Trevor W, and Sahakian, Barbara J
- Published
- 2006
- Full Text
- View/download PDF
38. Cognitive reserve in neuropsychiatry.
- Author
-
Barnett JH, Salmond CH, Jones PB, and Sahakian BJ
- Abstract
Background. The idea that superior cognitive function acts as a protective factor against dementia and the consequences of head injury is well established. Here we suggest the hypothesis that cognitive reserve is also important in neuropsychiatric disorders including schizophrenia, bipolar disorder and depression.Method. We review the history of passive and active models of reserve, and apply the concept to neuropsychiatric disorders. Schizophrenia is used as an exemplar because the effects of premorbid IQ and cognitive function in this disorder have been extensively studied.Results. Cognitive reserve may impact on neuropsychiatric disorders in three ways: by affecting the risk for developing the disorder, in the expression of symptoms within disorders, and in patients' functional outcome. Cognitive failure below a certain threshold may alone, or in combination with common psychiatric symptoms, produce neuropsychiatric syndromes.Conclusions. Consideration of cognitive reserve may considerably improve our understanding of individual differences in the causes and consequences of neuropsychiatric disorders. For these reasons, the concept of cognitive reserve should be incorporated in future studies of neuropsychiatric disorder. It may be possible to enhance cognitive reserve through pharmacological or non-pharmacological means, such as education, neurocognitive activation or other treatment programmes. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
39. Impaired cognition and decision-making in bipolar depression but no 'affective bias' evident.
- Author
-
Rubinsztein JS, Michael A, Underwood BR, Tempest M, and Sahakian BJ
- Abstract
Background. Depression is usually the predominant affective state in bipolar disorder. There are few studies, with discrepant views, examining the extent of cognitive impairment in patients with bipolar depression. To our knowledge, there are no previous studies examining decision-making ability or whether there is an affective attentional bias in bipolar depression.Method. We ascertained 24 depressed bipolar I patients from acute psychiatric hospital wards and out-patient clinics and 26 age- and IQ-matched healthy controls. Using computerized tests we evaluated their performance on 'neutral' (non-emotional) cognitive tasks (i.e. memory, attention and executive function) and on novel tasks of emotional cognition (i.e. the decision-making task and the affective go/no-go task).Results. Accuracy measures were significantly impaired on tests of visual and spatial recognition and attentional set-shifting in bipolar depression compared with age- and IQ-matched controls. The quality of decision-making was also significantly impaired in the patients. A mood-congruent attentional bias for 'sad' targets was not evident on the affective go/no-go task.Conclusions. We found widespread evidence of significant cognitive impairment and impaired quality of decision-making in symptomatically severe depressed bipolar patients. This cognitive impairment may contribute to difficulties with daily living, decision-making and the ability to engage and comply with psychological and drug treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
40. Profile of neurocognitive impairments associated with female in-patients with anorexia nervosa.
- Author
-
Fowler L, Blackwell A, Jaffa A, Palmer R, Robbins TW, Sahakian BJ, and Dowson JH
- Abstract
BACKGROUND: Although many studies have reported impairments of neurocognitive performance in patients with anorexia nervosa (AN), these have involved a wide range of assessment methods and some findings are inconsistent. METHOD: Twenty-five female in-patients with a DSM-IV diagnosis of AN, identified from three units specializing in the treatment of eating disorders, volunteered for the study. Twenty-five non-clinical control subjects were recruited, matched for age, gender and estimated IQ. Subjects were assessed with a range of computer-administered neurocognitive tasks from the Cambridge Neuropsychological Test Automated Battery (CANTAB), which has been validated in many studies of neuropsychiatric disorders. RESULTS: The patient group showed significant but moderate impairments (i.e. less than one standard deviation below the mean performance of the control group) on tests of spatial recognition memory, a planning task and rapid visual information processing, while a subgroup of patients (n = 14) showed greater degrees of impairments on at least one of these tests. The degrees of impairments did not correlate with body mass index (BMI). No impairments were observed on tests of spatial span, pattern recognition memory, spatial working memory, matching-to-sample, paired associates learning and set-shifting. CONCLUSIONS: The findings, in relation to a mean BMI of 15.3, are compatible with, in general, subtle impairments in neurocognition in AN. However, in those patients with relatively severe degrees of impairments, these may have adverse effects on complex tasks of social and occupational functioning. Further research is needed on the nature of relevant causal mechanisms, including the effects of potentially confounding variables. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
41. Strategy implementation in obsessive-compulsive disorder and trichotillomania.
- Author
-
Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, and Sahakian BJ
- Abstract
Background. The use of strategies to aid performance when undertaking neuropsychological tasks is dependent on intact fronto-striatal circuitry, and growing evidence suggests impaired spontaneous use of strategies in patients with obsessive-compulsive disorder (OCD). However, studies to date have not examined the effects of strategy training on task performance in OCD or in trichotillomania (compulsive hair-pulling, a condition that has been argued to share overlap with OCD in terms of phenomenology and co-morbidity).Method. The ability to generate novel visuospatial sequences using a computer interface was examined before and after undertaking optimal strategy training in 20 OCD patients, 17 trichotillomania patients, and 20 controls (matched for age, education, and IQ).Results. OCD patients failed to improve ability to generate novel sequences above baseline despite successfully completing strategy training to the same extent as other groups. In contrast, performance of trichotillomania patients improved significantly after training to the same extent as controls. Groups did not differ on memory span, trial-by-trial action monitoring, or ability to generate novel visuospatial sequences prior to strategy training.Conclusions. Strategy implementation deficits, suggestive of cognitive inflexibility and fronto-striatal dysfunction, appear integral to the neurocognitive profile of OCD but not trichotillomania. Future research should investigate cognitive flexibility in obsessive-compulsive spectrum disorders using a variety of paradigms, and clarify the contribution of specific neural structures and transmitter systems to deficits reported. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
42. Visuospatial learning and executive function are independently impaired in first-episode psychosis.
- Author
-
Barnett JH, Sahakian BJ, Werners U, Hill KE, Brazil R, Gallagher O, Bullmore ET, and Jones PB
- Abstract
Background. Demonstrating specific cognitive impairments in psychotic disorders is difficult. However, specific deficits in memory and executive functions have often been claimed. The Cambridge Neuropsychological Test Automated Battery (CANTAB) tasks of IDED attention-shifting (an executive task) and visuospatial paired associates learning (PAL, a memory task) require intact frontal and temporo-hippocampal functioning, respectively; both have been suggested as markers of disease progress in psychosis.Method. Seventy-one subjects with a first-episode psychosis or at-risk mental state were assessed on these two tasks during referral to a specialist service, the Cambridge-based CAMEO early intervention team.Results. Performance on the two tasks was dissociated. Poor performance on the PAL test was associated with increased symptom levels and poorer global function, while failure on the IDED executive test was not found to have significant clinical associations. Duration of illness was not associated with performance on either task.Conclusions. Visuospatial PAL failure may be a marker of clinical severity at the onset of psychosis while IDED performance may reflect a more stable, trait-like impairment. Dissociated performance on the executive and associative learning tasks may reflect independent, neurally dissociated impairments that do not arise in a fixed order. This may explain some of the heterogeneity of cognitive function seen in early psychosis. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
43. Executive function in Tourette's syndrome and obsessive-compulsive disorder.
- Author
-
Watkins LH, Sahakian BJ, Robertson MM, Veale DM, Rogers RD, Pickard KM, Aitken MRF, and Robbins TW
- Abstract
BACKGROUND: Cognitive performance was compared in the genetically and neurobiologically related disorders of Tourette's syndrome (TS) and obsessive-compulsive disorder (OCD), in three domains of executive function: planning, decision-making and inhibitory response control. METHOD: Twenty TS patients, twenty OCD patients and a group of age- and IQ-matched normal controls completed psychometric and computerized cognitive tests and psychiatric rating scales. The cognitive tests were well-characterized in terms of their sensitivity to other fronto-striatal disorders, and included pattern and spatial recognition memory, attentional set-shifting, and a Go/No-go set-shifting task, planning, and decision-making. RESULTS: Compared to controls, OCD patients showed selective deficits in pattern recognition memory and slower responding in both pattern and spatial recognition, impaired extra-dimensional shifting on the set-shifting test and impaired reversal of response set on the Go/No-go test. In contrast, TS patients were impaired in spatial recognition memory, extra-dimensional set-shifting, and decision-making. Neither group was impaired in planning. Direct comparisons between the TS and OCD groups revealed significantly different greater deficits for recognition memory latency and Go/No-go reversal for the OCD group, and quality of decision-making for the TS group. CONCLUSIONS: TS and OCD show both differences (recognition memory, decision-making) and similarities (set-shifting) in selective profiles of cognitive function. Specific set-shifting deficits in the OCD group contrasted with their intact performance on other tests of executive function, such as planning and decision-making, and suggested only limited involvement of frontal lobe dysfunction, possibly consistent with OCD symptomatology. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
44. Cognitive sequelae of head injury: involvement of basal forebrain and associated structures.
- Author
-
Salmond CH, Chatfield DA, Menon DK, Pickard JD, Sahakian BJ, Salmond, C H, Chatfield, D A, Menon, D K, Pickard, J D, and Sahakian, B J
- Published
- 2005
45. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.
- Author
-
McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins TW, and Sahakian BJ
- Abstract
BACKGROUND: It is now accepted that attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood. However, relative to the considerable literature concerning the profile of neurocognitive deficits associated with this disorder in childhood, equivalent investigations in adult populations have been less common. The current study examined cognitive function in adults diagnosed with ADHD employing well-validated neuropsychological tasks. METHOD: Nineteen adult patients who satisfied DSM-IV criteria for ADHD and 19 matched (gender, age and verbal IQ), non-clinical control subjects were recruited. Patients were either unmedicated or had abstained from a psychostimulant medication regime for at least 24 h prior to neurocognitive assessment. A functionally wide-ranging test battery was administered. RESULTS: Relative to controls, ADHD adults performed significantly worse on spatial working memory, planning, and attentional-set shifting tests and were significantly slower to respond to target stimuli on the go/no-go task. In contrast, the two subject groups performed equivalently on decision-making and pattern/spatial recognition memory assessments. CONCLUSIONS: The demonstration of neuropsychological dysfunction in the adult ADHD cohort provides some support for the validity of this diagnosis in adulthood. In particular, there is broad consistency between the cognitive profile revealed in the current investigation and that previously demonstrated in a study of medication-naïve ADHD children. There is evidence that frontostriatal function is especially disrupted. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
46. Profile of cognitive progression in early Huntington's disease.
- Author
-
Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ané M, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T, NEST-HD Consortium, Ho, A K, Sahakian, B J, Brown, R G, Barker, R A, Hodges, J R, Ané, M-N, and Snowden, J
- Published
- 2003
- Full Text
- View/download PDF
47. A case of unilateral neglect in Huntington's disease.
- Author
-
Ho AK, Manly T, Nestor PJ, Sahakian BJ, Bak TH, Robbins TW, Rosser AE, Barker RA, Cambridge Centre for Brain Repair, Cambridge University, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK; aileenkho@netscape.net, Ho, Aileen K, Manly, Tom, Nestor, Peter J, Sahakian, Barbara J, Bak, Thomas H, Robbins, Trevor W, Rosser, Anne E, and Barker, Roger A
- Abstract
Unilateral neglect, an attentional deficit in detecting and acting on information coming from one side of space, is a relatively common consequence of right hemisphere stroke. Although neglect has been observed following damage to a variety of brain structures, to date no reports exist of neglect phenomena arising from Huntington's Disease (HD). However, reports in the animal and human literature suggest that neglect is possible following damage to a primary site for Huntington's pathology, the basal ganglia. Here we present a patient (BG) with genetically proven HD who, in the context of the mild intellectual, executive and attentional impairments associated with the disorder, showed a remarkably severe and stable neglect for left space. MRI and electrophysiological results make it unlikely that the spatial bias could be accounted for by basic sensory loss. In addition, behavioural investigation indicated that, although BG's neglect operated in a very striking manner along body-centred co-ordinates (missing almost all information presented to her left), more general limitations in visual attention were apparent to the left-side of information presented entirely to the right of the body midline. Further evidence is presented showing that the neglect was manifest on tactile and auditory tasks as well as those presented in the visual domain. The presence of neglect in HD in this case is novel and somewhat puzzling, particularly as flourodeoyglucose positron emission tomography revealed bilateral caudate hypoperfusion. Reducing the statistical threshold on this analysis revealed a potential frontal hypometabolism that was more marked in the right than left hemisphere. However, as this was only apparent at a threshold below that normally considered acceptable (due to the resulting number of false positives), this possible account of the neglect must be viewed very cautiously. [ABSTRACT FROM AUTHOR]
- Published
- 2003
48. Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study.
- Author
-
Iddon JL, Pickard JD, Cross JJL, Griffiths PD, Czosnyka M, Sahakian BJ, Iddon, J L, Pickard, J D, Cross, J J, Griffiths, P D, Czosnyka, M, and Sahakian, B J
- Abstract
Objectives: Eleven patients with idiopathic normal pressure hydrocephalus (NPH) were selected from an initial cohort of 43 patients. The patients with NPH fell into two distinctive subgroups: preshunt, group 1 (n=5) scored less than 24 on the mini mental state examination (MMSE) and were classified as demented and group 2 (n=6) scored 24 or above on the MMSE and were classified as non-demented.Methods: All patients were neuropsychologically assessed on two occasions: preshunt and then again 6 months postshunt. Group 1 completed the mini mental state examination (MMSE) and the Kendrick object learning test (KOLT). In addition to the MMSE and KOLT, group 2 completed further tasks including verbal fluency and memory and attentional tasks from the CANTAB battery. Nine of the 11 patients also underwent postshunt MRI.Results: Group 1, who, preshunt, performed in the dementing range on both the MMSE and KOLT, showed a significant postoperative recovery, with all patients now scoring within the normal non-demented range. Group 2, although showing no signs of dementia according to the MMSE and KOLT either preshunt or postshunt, did show a specific pattern of impairment on tests sensitive to frontostriatal dysfunction compared with healthy volunteers, and this pattern remained postoperatively. Importantly, this pattern is distinct from that exhibited by patients with mild Alzheimer's disease. Eight of the nine patterns of structural damage corresponded well to cognitive performance.Conclusions: These findings are useful for three main reasons: (1) they detail the structural and functional profile of impairment seen in NPH, (2) they demonstrate the heterogeneity found in this population and show how severity of initial cognitive impairment can affect outcome postshunt, and (3) they may inform and provide a means of monitoring the cognitive outcome of new procedures in shunt surgery. [ABSTRACT FROM AUTHOR]- Published
- 1999
49. Evidence for specific cognitive deficits in preclinical Huntington's disease.
- Author
-
Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, and Sahakian BJ
- Published
- 1998
50. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease.
- Author
-
Lawrence, AD, Weeks, RA, Brooks, DJ, Andrews, TC, Watkins, LHA, Harding, AE, Robbins, TW, and Sahakian, BJ
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.